A Study of Single and Multiple SC Doses of ALXN1830 in Healthy Adult Participants

Trial Identifier:	ALXN1830-HV-105
Sponsor:	Alexion Pharmaceuticals
NCTID::	NCT05254613
Start Date:	November 2019
Primary Completion Date:	January 2021
Study Completion Date:	January 2021
Condition:	Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
United Kingdom	London, United Kingdom

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.